GFI: Dear Health Care Provider Letters; Improving Communication of Important Safety Information
Extension without change of a currently approved collection
No
Regular
Approved without change
01/23/2017
10/24/2016
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
01/31/2020
36 Months From Approved
01/31/2017
25
0
30
2,500
0
3,000
0
0
0
This information collection request supports agency guidance regarding "Dear Healthcare Provider" Letters. Respondents to the collection are manufacturers and distributors of drugs for which such a letter is required under 21 CFR part 200.5. The burden reflects the estimated time associated with the coordination and preparation of these letters with respondents so that they may be issued accordingly. The letters communicate new and important information about prescription drug and biological products (drugs).
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.